FARIA, RITA, SARAMAGO, P, COX, E, WENG, STEPHEN, IYEN, BARBARA, AKYEA, RALPH, HUMPHRIES, SE, QURESHI, NADEEM and WOODS, BETH, 2022. What Are the Benefits of Treatment of Familial Hypercholesterolaemia? A Cost-Effectiveness Model Based on Real-World Data Considering Cholesterol Burden Value in Health. 25(1), S60
FARIA, R, COX, E, SARAMAGO, P, HARALAMBOS, K, WATSON, M, HUMPHRIES, SE, QURESHI, N and WOODS, B, 2022. Better Outcomes and Value for Money with Cost-Effectiveness Modelling of Cascade Screening Strategies for Familial Hypercholesterolaemia Value in Health. 25(1), S9
WALKER, SIMON MARK, COX, EDWARD, REVILL, PAUL, MUSIIME, VICTOR, BWAKURA-DANGAREMBIZI, MUTSA, MALLEWA, JANE, CHERUIYOT, PRISCILLA, MAITLAND, KATHRYN, FORD, NATHAN, GIBB, DM and OTHERS, 2020. The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa Journal of the international aids society.
WALKER, SIMON, COX, EDWARD, ROTHWELL, BEN, BERRY, COLIN, MCCANN, GERRY P, BUCCIARELLI-DUCCI, CHIARA, DALL ARMELLINA, ERICA, PRASAD, ABHIRAM, FOLEY, JAMES ROBERT JOHN, MANGION, KENNETH, BIJSTERVELD, PETRA, EVERETT, COLIN, STOCKEN, DEBORAH, PLEIN, SVEN, GREENWOOD, JOHN P and SCULPHER, MARK, 2020. Cost-effectiveness of cardiovascular imaging for stable coronary heart disease Heart. COX, EDWARD, SARAMAGO, PEDRO, KELLY, JOHN, PORTA, NURIA, HALL, EMMA, TAN, WEI SHEN, SCULPHER, MARK and SOARES, MARTA, 2019. The Impacts of Bladder Cancer on UK Healthcare Costs and Patients’ Health-Related Quality of Life: Evidence from the BOXIT Trial Clinical Genitourinary Cancer.
COX, EDWARD, WADE, ROS, PERON, MATHILDE, DIETZ, KRISTINA CHARLOTTE, EASTWOOD, ALISON, PALMER, STEPHEN and GRIFFIN, SUSAN, 2019. The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal PharmacoEconomics. 1-11
SOUTH, EMILY, COX, EDWARD, MEADER, NICK, WOOLACOTT, NERYS and GRIFFIN, SUSAN, 2019. Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation PharmacoEconomics-open. 3(2), 151-161
COX, EDWARD, MEADER, NICK, SOUTH, EMILY, HARDEN, MELISSA, NERYS, WOOLACOTT and GRIFFIN, SUSAN, 2017. Evidence Review Group’s Report - Strimvelis for treating severe combined immunodeficiency caused by adenosine deaminase deficiency National Insitiute for Health and Care Technology.
WADE, ROS, COX, EDWARD, PERON, MATHILDE, DIETZ, KRISTINA CHARLOTTE, EASTWOOD, ALISON, PALMER, STEPHEN and GRIFFIN, SUSAN, 2016. Evidence Review Group’s Report - Inotuzumab ozogamicin for treating relapsed or refractory Bcell acute lymphoblastic leukaemia National Insitiute for Health and Care Technology.
COX, E, WALKER, S, BLOWER, S, BYWATER, T, SAMPAIO , F and RICHARDSON, G, The cost-effectiveness of a proportionate parenting programme for primary caregivers and their child: an economic evaluation using evidence from the E-SEE Trial BMC Health Services Research.
COX, EDWARD, CORBETT, MARK, GONCALVES, PEDRO SARAMAGO, MELTON, HOLLIE, HARDEN, MELISSA, WALKER, SIMON, DIAS, SOFIA, ROTHERY, CLAIRE and EASTWOOD, ALISON, Evidence Review Group’s Report Avatrombopag in combination for treating chronic immune thrombocytopenia National Insitiute for Health and Care Technology.
QURESHI1, N, WOODS, B, FARIA, R, SARAMAGO, P, COX, E, BEE1, J, CONDON1, L, WENG, S, AKYEA1, R, IYEN1, B, RODERICK, P, HUMPHRIES, S, ROWLANDS, W, WATSON, M, HARALAMBOS, K, KENNY, R, DATTA, D, MIEDZYBRODZKA11, Z, BYRNE1, C and KAI1, J, Evaluating alternative protocols for identifying and managing patients with familial hypercholesterolaemia: cost effectiveness analysis with qualitative study National Insitiute for Health Research.
BYWATER, T, BERRY, V, BLOWER, S, BURSNALL, M, COX, E, MASON-JONES, A, MCGILLOWAY, S, MCKENDRICKC, K, MITCHELL, S, PICKETT, K, RICHARDSON, G, SOLAIMAN, K, TEARE, M, WALKER, S and WHITTAKERG, K, Social-Emotional Wellbeing: A Proportionate Universal Randomised Controlled Trial of the Incredible Years® Infant and Toddler Parenting Programmes (E-SEE STEPS) National Insitiute for Health Research.
CLEMES, S, VARELA-MATO1, V, BODICOAT, D, BROOKES, C, CHEN, Y, COX, E, EDWARDSON, C, GRAY, L, GUEST, A, JOHNSON, V, MUNIR, F, PAINE, N, RICHARDSON, G, RUETTGER, K, SAYYAH1, M, SHERRY, A, PAOLA, A, TROUGHTON, J, WALKER, S, YATES, T and KING, J, The effectiveness and cost-effectiveness of a Structured Health Intervention For Truckers (SHIFT): A cluster randomised controlled trial (RCT) National Insitiute for Health Research.
EDWARDSON, C, MAYLOR, B, BIDDLE, S, CLEMES, S, COX, E, DAVIES, M, DUNSTAN, D, EBORALL, H, GRANAT11, M, GRAY, L, HADJICONSTANTINOU1, M, HEALY, G, JAICIM, N, LAWTON11, S, MANDALIA, P, MUNIR, F, RICHARDSON, G, WALKER, S, YATES, T and CLARKE-CORNWELL, A, A three-arm cluster randomised controlled trial to test the effectiveness and cost-effectiveness of the SMART Work & Life intervention for reducing daily sitting time in office workers National Insitiute for Health Research.